Bicycle Therapeutics plc Proceeds from Issuance of Debt
Bicycle Therapeutics plc (BCYC) reported Proceeds from Issuance of Debt of $15.00 million for the 12-month period ending 2021-12-31, per its 10-K filed 2024-02-20.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2024-02-20
- Bicycle Therapeutics plc proceeds from issuance of debt for the quarter ending 2021-12-31 was $0.00.
- Bicycle Therapeutics plc proceeds from issuance of debt for the quarter ending 2021-09-30 was $0.00.
- Bicycle Therapeutics plc proceeds from issuance of debt for the quarter ending 2021-06-30 was $0.00.
- Bicycle Therapeutics plc proceeds from issuance of debt for the quarter ending 2021-03-31 was $15.00M.
- Bicycle Therapeutics plc proceeds from issuance of debt for fiscal 2021 was $15.00M, a 0.00% change from fiscal 2020.
- Bicycle Therapeutics plc proceeds from issuance of debt for fiscal 2020 was $15.00M.
| Period end | Proceeds from Issuance of Debt 3 month | Proceeds from Issuance of Debt 6 month | Proceeds from Issuance of Debt 9 month | Proceeds from Issuance of Debt 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $0.00 derived: sum of 2 quarters · filed 2024-02-20 | $0.00 derived: sum of 3 quarters · filed 2024-02-20 | $15.00M 10-K · filed 2024-02-20 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $15.00M 10-Q · filed 2022-11-03 | $15.00M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $15.00M 10-Q · filed 2022-08-04 | $15.00M derived: sum of 3 quarters · filed 2023-02-28 | |
| 2021-03-31 | $15.00M 10-Q · filed 2022-05-05 | $15.00M derived: sum of 2 quarters · filed 2023-02-28 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $15.00M 10-K · filed 2023-02-28 | ||
| 2020-09-30 | $15.00M 10-Q · filed 2021-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |